Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients

Immunology and Cell Biology

Volumn 88, Issue 2, 2010, Pages 125-135

  Wynn, Katherine K ^a,b   Crough, Tania ^a   Campbell, Scott ^b   McNeil, Keith ^b   Galbraith, Andrew ^b   Moss, Denis J ^a   Silins, Sharon L ^a   Bell, Scott ^b   Khanna, Rajiv ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CMV disease; Epstein Barr virus; Post transplant lymphomas; T cells; T cell receptor; Transplantation

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; FOSCARNET; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLIGOCLONAL BAND; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN; THYMOCYTE ANTIBODY; VALACICLOVIR; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BLOOD; CELL EXPANSION; CELL FUNCTION; CELL LOSS; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; GRAFT REJECTION; HERPES VIRUS INFECTION; HUMAN; HUMAN CYTOMEGALOVIRUS; ORGAN TRANSPLANTATION; SOLID ORGAN TRANSPLANTATION; SYMPTOM; T LYMPHOCYTE; VIRUS INFECTION; VIRUS LOAD;

ADULT; AGED; CELL PROLIFERATION; EPITOPES; HERPESVIRIDAE INFECTIONS; HUMANS; MIDDLE AGED; ORGAN TRANSPLANTATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECURRENCE; T-LYMPHOCYTES; VIRAL LOAD;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5;

EID: 77149139123     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.74     Document Type: Article

References (67)

1. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 1990; 12(Suppl 7): S745-S753.
2. Plotkin SA. Vaccination against cytomegalovirus, the changeling demon. Pediatr Infect Dis J 1999; 18: 313-325; quiz 26.
3. Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343: 481-492.
4. Goodrich JM, Mori M, Gleaves CA, Du Mond C, Cays M, Ebeling DF et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991; 325: 1601-1607.
5. Singh N. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies. J Clin Virol 2006; 35: 474-477.
6. Ljungman P, Engelhard D, Link H, Biron P, Brandt L, Brunet S et al. Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group. Clin Infect Dis 1992; 14: 831-835.
7. Reusser P, Riddell SR, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991; 78: 1373-1380.
8. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes 2003; 10: 60-65.
9. Matsutani T, Yoshioka T, Tsuruta Y, Iwagami S, Toyosaki-Maeda T, Horiuchi T et al. Restricted usage of T-cell receptor alpha-chain variable region (TCRAV) and T-cell receptor beta-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation. Br J Haematol 2000; 109: 759-769.
10. Dietrich PY, Caignard A, Diu A, Genevee C, Pico JL, Henry-Amar M et al. Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood 1992; 80: 2419-2424.
11. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, Friedman SM et al. Human HLAA0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 1995; 181: 79-91.
12. Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302: 575-581.
13. Cabaniols JP, Fazilleau N, Casrouge A, Kourilsky P, Kanellopoulos JM. Most alpha/beta T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J Exp Med 2001; 194: 1385-1390.
14. Rock EP, Sibbald PR, Davis MM, Chien YH. CDR3 length in antigen-specific immune receptors. J Exp Med 1994; 179: 323-328.
15. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16: 176-181.
16. Pilch H, Hohn H, Freitag K, Neukirch C, Necker A, Haddad P et al. Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol 2002; 9: 257-266.
17. Davis MM, Chien YH In: Paul WE (ed). Fundamental Immunology. Philadelphia: Lippincott-Raven, 1999, 341-366.
18. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 2006; 6: 883-894.
19. Kolopp-Sarda MN, Renoult E, Gregoire MJ, Bene MC, Kessler M, Faure GC. Increased usage of TCR V-beta8 in kidney transplant recipients with aberrant immune reconstitution and clinical complications. Transplantation 1999; 67: 1441-1446.
20. Vandevyver C, Mertens N, van den Elsen P, Medaer R, Raus J, Zhang J. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur J Immunol 1995; 25: 958-968.
21. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994; 152: 5581-5592.
22. Mor F, Cohen IR. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis. J Clin Invest 1993; 92: 2199-2206.
23. Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA et al. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol 1999; 163: 3530-3538.
24. Giuggio VM, Bonkovsky HL, Rothman AL. Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection. Viral Immunol 2005; 18: 179-189.
25. Vigan I, Jouvin-Marche E, Leroy V, Pernollet M, Tongiani-Dashan S, Borel E et al. T lymphocytes infiltrating the liver during chronic hepatitis C infection express a broad range of T-cell receptor beta chain diversity. J Hepatol 2003; 38: 651-659.
26. Price DA, West SM, Betts MR, Ruff LE, Brenchley JM, Ambrozak DR et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004; 21: 793-803.
27. Messaoudi I, Guevara Patino JA, Dyall R, LeMaoult J, Nikolich-Zugich J. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 2002; 298: 1797-1800.
28. Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol 2004; 4: 123-132.
29. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999; 402: 255-262.
30. Argaet VP, Schmidt CW, Burrows SR, Silins SL, Kurilla MG, Doolan DL et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med 1994; 180: 2335-2340.
31. Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996; 2: 906-911.
32. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 2005; 202: 1349-1361.
33. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T- cell receptor usage of pp65-specific CTL. J Virol 1996; 70: 7569-7579.
34. Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows SR, Burrows JM et al. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J Exp Med 1996; 184: 1815-1824.
35. Smith TJ, Terada N, Robinson CC, Gelfand EW. Acute infectious mononucleosis stimulates the selective expression/expansion of V beta 6.1-3 and V beta 7 T cells. Blood 1993; 81: 1521-1526.
36. Silins SL, Sherritt MA, Silleri JM, Cross SM, Elliott SL, Bharadwaj M et al. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood 2001; 98: 3739-3744.
37. Simmons RL, Migliori RJ. Infection prophylaxis after successful organ transplantation. Transplant Proc 1988; 20: 7-11.
38. Miller JL, Ericson SG. Cyclosporin a and tacrolimus (FK506) differentially alter T-cell receptor expression in vivo. Immunopharmacol Immunotoxicol 2007; 29: 105-118.
39. Bloemena E, van Lier RA, van Oers MH, Weinreich S, Stilma-Meinesz AP, Schellekens PT. The effects of prednisolone and cyclosporin A on monocyte-dependent and -independent human T-cell proliferation in vitro. Transplant Proc 1989; 21: 861-865.
40. Hirokawa M, Matsutani T, Horiuchi T, Kawabata Y, Kitabayashi A, Yoshioka T et al. Extensive clonal expansion of T lymphocytes causes contracted diversity of complementarity-determining region 3 and skewed T cell receptor repertoires after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2001; 27: 607-614.
41. Crough T, Fazou C, Weiss J, Campbell S, Davenport MP, Bell SC et al. Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response. J Virol 2007; 81: 11538-11542.
42. Mattes FM, Vargas A, Kopycinski J, Hainsworth EG, Sweny P, Nebbia G et al. Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant 2008; 8: 990-999.
43. La Rosa C, Krishnan A, Longmate J, Martinez J, Manchanda P, Lacey SF et al. Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease. J Infect Dis 2008; 197: 25-33.
44. Holm M, Pettersen FO, Kvale D. PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples. Curr HIV Res 2008; 6: 49-58.
45. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993; 362: 758-761.
46. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 2005; 6: 873-879.
47. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004; 78: 5535-5545.
48. Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 2007; 85: 46-54.
49. Vivier E, Malissen B. Innate and adaptive immunity: specificities and signaling hierarchies revisited. Nat Immunol 2005; 6: 17-21.
50. Cervera C, Filella X, Linares L, Pineda M, Esteva C, Anton A et al. TH1/TH2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation. Transplant Proc 2007; 39: 2233-2235.
51. Essa S, Raghupathy R, Pacsa AS, El-Shazly A, Said T, Azizieh F. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection. J Med Virol 2000; 60: 223-229.
52. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008; 8: 247-258.
53. Isaksson A, Berggren M, Ekeland-Sjoberg K, Samuelsson T, Ricksten A. Cell specific internal translation efficiency of Epstein-Barr virus present in solid organ transplant patients. J Med Virol 2007; 79: 573-581.
54. Berggren MA, Isaksson A, Larsson U, Nilsson F, Nystrom U, Ekman T et al. Alternative EBNA1 expression in organ transplant patients. J Med Virol 2005; 76: 378-385.
55. Goodrum F, Reeves M, Sinclair J, High K, Shenk T. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 2007; 110: 937-945.
56. Cheung AK, Abendroth A, Cunningham AL, Slobedman B. Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 2006; 108: 3691-3699.
57. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-768.
58. van de Berg PJ, van Stijn A, Ten Berge IJ, van Lier RA. A fingerprint left by cytomegalovirus infection in the human T cell compartment. J Clin Virol 2008; 41: 213-217.
59. Streblow DN, Orloff SL, Nelson JA. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007; 19: 577-582.
60. Shepherd RW, Turmelle Y, Nadler M, Lowell JA, Narkewicz MR, McDiarmid SV et al. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 2008; 8: 396-403.
61. McNeil K, Glanville AR, Wahlers T, Knoop C, Speich R, Mamelok RD et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation 2006; 81: 998-1003.
62. Gault E, Michel Y, Dehee A, Belabani C, Nicolas JC, Garbarg-Chenon A. Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 2001; 39: 772-775.
63. Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE et al. Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation 2003; 75: 1556-1560.
64. Khanna R, Burrows SR. Role of cytotoxic T lymphocytes in Epstein-Barr virusassociated diseases. Annu Rev Microbiol 2000; 54: 19-48.
65. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol 2004; 125: 267-281.
66. Merrifield B. Concept and early development of solid-phase peptide synthesis. Methods Enzymol 1997; 289: 3-13.
67. Elkington R, Walker S, Crough T, Menzies M, Tellam J, Bharadwaj M et al. Ex vivo profiling of CD8+ T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 2003; 77: 5226-5240.